Agent for treating atrial fibrillation

Details Agent for treating atrial fibrillation Agent for treating atrial fibrillation

A - Human Necessities

61

K

A61K 31/4725 (2006.01) A61K 31/55 (2006.01) A61K 45/00 (2006.01) A61P 9/06 (2006.01) C07D 401/06 (2006.01)

Patent

CA 2617519

Disclosed is a therapeutic agent for atrial fibrillation comprising an If current inhibitor, particularly (-)-N-[2-[(R)-3-(6,7-dimethoxy-1,2,3,4- tetrahydro- isoquinoline-2-carbonyl)piperidino]ethyl]-4-fluorobenzamide monophosphate, as an active ingredient. This active ingredient has more preferred properties for use as a therapeutic agent for atrial fibrillation compared to verapamil (a Ca antagonist) and atenolol (a .beta.-blocker) which have been conventionally used as the therapeutic agents for atrial fibrillation.

La présente invention concerne un agent thérapeutique de la fibrillation auriculaire comportant un inhibiteur courant I<SUB>f</SUB> , particulièrement un monosphosphate (-)-N-[2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydro- isoquinoline-2-carbonyl)piperidino]ethyl]-4-fluorobenzamide comme ingrédient actif. Cet ingrédient actif comporte des propriétés préférées à utiliser comme agent thérapeutique pour la fibrillation auriculaire comparé au vérapamil (un antagoniste Ca) et à l'aténolol (un bloqueur ß) qui ont été utilisés conventionnellement comme agent thérapeutique de la fibrillation auriculaire.

Affiliated with

Also associated with

Rating

Agent for treating atrial fibrillation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treating atrial fibrillation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating atrial fibrillation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1979681